The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Trastuzumab (T) plus gemcitabine-cisplatin (GC) for treatment naïve HER2 positive biliary tract adenocarcinomas (BTC): A multicentre open-label, phase II study (TAB).
 
Vikas S. Ostwal
Research Funding - BDR Pharmaceutics (Inst); Cadila Pharmaceuticals (Inst); Dr. Reddy's Laboratories (Inst); Intas (Inst); Lupin Pharmaceuticals (Inst)
Travel, Accommodations, Expenses - AstraZeneca
 
Sarika Mandavkar
No Relationships to Disclose
 
Prabhat Ghanshyam Bhargava
Honoraria - Intas (Inst); Merck (Inst)
Consulting or Advisory Role - Lupin Pharmaceuticals (Inst); Mankind Pharma (Inst)
Speakers' Bureau - Novartis (Inst); Zydus Pharmaceuticals (Inst)
 
Sujay Srinivas
No Relationships to Disclose
 
Chaitali Nashikkar
No Relationships to Disclose
 
Omshree Shetty
No Relationships to Disclose
 
Rajiv Kumar Kaushal
No Relationships to Disclose
 
Subhash Yadav
No Relationships to Disclose
 
Aekta Shah
No Relationships to Disclose
 
Akshay Dwarka Baheti
No Relationships to Disclose
 
Suman Kumar Ankathi
No Relationships to Disclose
 
Daksha Mehta
No Relationships to Disclose
 
Akhil Kapoor
No Relationships to Disclose
 
Mahesh Goel
No Relationships to Disclose
 
Shraddha Patkar
No Relationships to Disclose
 
Deepali Chaugule
No Relationships to Disclose
 
Anant Ramaswamy
No Relationships to Disclose